Hepatitis E virus and neurologic disorders

Emerging Infectious Diseases

Volumn 17, Issue 2, 2011, Pages 173-179

  Kamar, Nassim ^a,b   Bendall, Richard P ^c   Peron, Jean Marie ^b,d   Cintas, Pascal ^a   Prudhomme, Laurent ^e   Mansuy, Jean Michel ^d   Rostaing, Lionel ^a,b   Keane, Frances ^c   Ijaz, Samreen ^f   Izopet, Jacques ^b,d   Dalton, Harry R ^c,g  

^a CHU RANGUEIL   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c ROYAL CORNWALL HOSPITALS NHS TRUST   (United Kingdom)

^d CHU PURPAN   (France)

^e Centre Hospitalier de Castres   (France)

^f PUBLIC HEALTH ENGLAND   (United Kingdom)

^g PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR PLUS LAMIVUDINE; ANTIINFECTIVE AGENT; EFAVIRENZ; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; FOSCARNET SODIUM; IMMUNOGLOBULIN; LOPINAVIR PLUS RITONAVIR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PEGINTERFERON ALPHA2A PLUS RIBAVIRIN; PREDNISOLONE; TACROLIMUS;

ADD ON THERAPY; ADULT; ARM WEAKNESS; ARTICLE; ATAXIA; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROPHYSIOLOGY; FEMALE; GENOTYPE; GRAFT RECIPIENT; GUILLAIN BARRE SYNDROME; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOCOMPETENCE; KIDNEY PANCREAS TRANSPLANTATION; KIDNEY TRANSPLANTATION; LIMB WEAKNESS; LIVER FUNCTION TEST; LOW BACK PAIN; LOW DRUG DOSE; MALE; MUSCLE WEAKNESS; NEURITIS; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PARESTHESIA; PHYSICAL EXAMINATION; POLYRADICULONEUROPATHY; WALKING DIFFICULTY;

ACUTE DISEASE; ADULT; CHRONIC DISEASE; FEMALE; FRANCE; GREAT BRITAIN; GUILLAIN-BARRE SYNDROME; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES;

EID: 79551633756     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1702.100856     Document Type: Article

References (18)

1. Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis. 2008;8:698-709. DOI: 10.1016/S1473-3099(08)70255-X
2. Dalton HR, Stableforth W, Thurairajah P, Hazeldine S, Remnarace R, Usama W, et al. Autochthonous hepatitis E in southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur J Gastroenterol Hepatol. 2008;20:784-790. DOI: 10.1097/MEG.0b013e3282f5195a
3. Kamar N, Selves J, Mansuy JM, Ouezzani L, Peron JM, Guitard J, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med. 2008;358:811-817. DOI: 10.1056/NEJMoa0706992
4. Ollier L, Tieulie N, Sanderson F, Heudier P, Giordanengo V, Fuzibet J, et al. Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann Intern Med. 2009;150:430-1.
5. Dalton HR, Bendall R, Keane F, Tedder R, Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med. 2009;361:1025-7. DOI: 10.1056/NEJMc0903778
6. Gerolami R, Moal V, Colson P. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med. 2008;358:859-60. DOI: 10.1056/NEJMc0708687
7. Kamar N, Mansuy JM, Cointault O, Selves J, Abravanel F, Danjoux M, et al. Hepatitis E virus-related cirrhosis in kidney- and kidneypancreas- transplant recipients. Am J Transplant. 2008;8:1744-8. DOI: 10.1111/j.1600-6143.2008.02286.x
8. Haagsma EB, van den Berg AP, Porte RJ, Benne CA, Vennema H, Reimerink JH, et al. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl. 2008;14:547-53. DOI: 10.1002/lt.21480
9. Kamani P, Baijal R, Amarapurkar D, Gupte P, Patel N, Kumar P, et al. Guillain-Barré syndrome associated with acute hepatitis E. Indian J Gastroenterol. 2005;24:216.
10. Sood A, Midha V, Sood N. Guillain-Barré syndrome with acute hepatitis E. Am J Gastroenterol. 2000;95:3667-3668.
11. Loly JP, Rikir E, Seivert M, Legros E, Defrance P, Belaiche J, et al. Guillain-Barré syndrome following hepatitis E. World J Gastroenterol. 2009;15:1645-1647. DOI: 10.3748/wjg.15.1645
12. Fong F, Illahi M. Neuralgic amyotrophy associated with hepatitis E virus. Clin Neurol Neurosurg. 2009;111:193-195. DOI: 10.1016/j.clineuro.2008.09.005
13. Mandal K, Chopra N. Acute transverse myelitis following hepatitis E virus infection. Indian Pediatr. 2006;43:365-366.
14. Rianthavorn P, Thongmee C, Limpaphayom N, Komolmit P, Theamboonlers A, Poovorawan Y. The entire genome sequence of hepatitis E virus genotype 3 isolated from a patient with neuralgic amyotrophy. Scand J Infect. Dis. 2010;42:395-400.
15. Kamar N, Izopet J, Cintas P, Garrouste C, Uro-Coste E, Cointault O, et al. Hepatitis E virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis. Am J Transplant. 2010;10:1321-1324. DOI: 10.1111/j.1600-6143.2010.03068.x
16. Mansuy JM, Peron JM, Abravanel F, Poirson H, Dubois M, Miedouge M, et al. Hepatitis E in the south west of France in individuals who have never visited an endemic area. J Med Virol. 2004;74:419-424. DOI: 10.1002/jmv.20206
17. Legrand-Abravanel F, Mansuy JM, Dubois M, Kamar N, Peron JM, Rostaing L, et al. Hepatitis E virus genotype 3 diversity, France. Emerg Infect Dis. 2009;15:110-4.
18. Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet. 2005;366:1653-66. DOI: 10.1016/S0140-6736(05)67665-67669